维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="NATAF J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Experimental allergic encephaslomyelitis is inhibited in transgenic mice expressing human C-reactive protein显示文摘	Szalai A J Nataf S Hu XZ	2002	J Immunol2002，168，6：	1
2	Pure red-cell aplasia and antierythropoietia antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B Kolta A Kiladjian JJ Philippe MD	2002	N Engl J Med2002，346，7：	1
3	Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，7：	1
4	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，7：	1
5	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant显示文摘	Casadevall N Nataf J Viron B	2002	Erythropoietin2002，346，：	1
6	Diagnostic and prognostic value of Cyfra21 - 1 compared with other tumor markers in patients with non-small lung cancer: a prospective study of 116 patients 显示文摘	Brechot JM Chevret S Nataf J	1997	Eur J Cancer1997，33，3：	1
7	Two-or threedimensional natural and mixing convection using modulate zonal models in buildings显示文摘	Wurtz E Nataf J M Winkelmann F	1999	International Journal of Heat and Mass Transfer1999，42，5：	1
8	Diagnostic and prognostic value of CYFRA21-1 compared with other tumor markers in patients with NSCLC: a prospective study of 116 patients显示文摘	Brechot JM Chevret S Nataf J	1997	Eur J Cancer1997，33，3：	1
9	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythro poietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，：	1
10	Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，：	1
11	A simple method for inverting the azimuthal anisotropy of surface waves显示文摘	Montagner J P Nataf H C	1986	J Geophys Res1986，91，：	1
12	Diagnostic and prognostic value of Cyfra 21-1com pared with other tumor markersin patients with non-small cell lung cancer:a prospectivestudy of 116 patients显示文摘	Brechot JM Chevret S Nataf J	1997	Eur J Cancer1997，33，3：	1
13	Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Nataf J Viron B	2002	N Engl J Med2002，346，7：	1
14	Diagnostic and brognostic value of cyfra 21-1 compared with other tumor marker in patients with NSCLC:a prospective of 116 patients显示文摘	Brechot JM Cheveret S Nataf J	2003	Eur J Cancer2003，33，：	1
15	Pure Red - cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombi-nant Erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	New England Journal of Medicine2002，346，7：	1
16	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	CASADEqALL N NATAF J VIRON B	2002	N Engl J Med2002，346，7：	1
17	Diagnostic and prognostic value of Cyfra Z1-1 compared with other tumor markers in pa- tients with NSCLSA prospective study of 116 patients显示文摘	Brechot J M Chevret S Nataf	1997	Eur J Cancer1997，33，3：	1
18	Diagnostic and prognostic value of Cyfra21-1 compared with other tumour markers in patients with non-small lung cancer:a prospective study of 116 patients显示文摘	Brechot JM Chevret S Nataf J	1997	Eur J Cancer1997，33，3：	1
19	Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，7：	1
20	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin显示文摘	Casadevall N Nataf J Viron B	2002	N Engl J Med2002，346，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示